Loading...
Market
Will Japan approve LSCD treatment using iPSCs by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Announcements from Japan's Ministry of Health, Labour and Welfare or equivalent regulatory bodies
Story
Osaka University Researchers Restore Vision in Four Patients with Limbal Stem Cell Deficiency Using Stem Cells
Nov 9, 2024, 02:36 PM
Researchers from Osaka University have achieved a significant breakthrough in treating blindness caused by limbal stem cell deficiency (LSCD) using induced pluripotent stem cells (iPSCs). In a first-of-its-kind interventional study conducted in Japan, the team performed corneal transplant surgery on four patients, with promising results. The study, which was a single-arm, open-label trial, demonstrated rapid vision improvement in all patients post-transplant, with their improved vision remaining stable over time. Notably, only one patient experienced a decline in vision during the initial year following the procedure. This innovative approach marks a pivotal advancement in regenerative medicine and offers new hope for individuals suffering from LSCD.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Parkinson's Disease • 25%
Heart Disease • 25%
Spinal Cord Injury • 25%
Other • 25%
United Kingdom • 25%
Canada • 25%
Australia • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0 countries • 25%
1-2 countries • 25%
3-4 countries • 25%
5 or more countries • 25%
